|

Exemestane tablets Clinical Trials

3 actively recruiting trials

▲ +1 trial since May 2026

Pipeline

Phase 3: 3

Top Sponsors

  • Shandong Suncadia Medicine Co., Ltd.2
  • Jiangsu Simcere Pharmaceutical Co., Ltd.1

Indications

  • Breast Cancer3
  • Cancer3
  • Locally Advanced Breast Cancer1
  • Metastatic Breast Cancer1
  • Locally Advanced or Metastatic Breast Cancer1

Other3 trials

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Phase 3
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
Phase 3
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.